Invesco Exchange-Traded Fund Trust. Holdings as of Jul 31, 2026, from Form N-PORT.
Share of net assets at the report date, for the whole fund across all share classes.
| Holding | Weight | Value | Shares or units |
|---|---|---|---|
| Invesco Private Prime FundCash or money market | 12.89% | $36.34M | 36,338,961 |
| Regeneron Pharmaceuticals, Inc.REGN | 5.47% | $15.43M | 20,233 |
| Amgen Inc.AMGN | 5.22% | $14.72M | 38,223 |
| CareDx, Inc.CDNA | 5.04% | $14.21M | 325,179 |
| Vertex Pharmaceuticals Inc.VRTX | 4.99% | $14.06M | 29,460 |
| Invesco Private Government FundCash or money market | 4.97% | $14.00M | 14,001,686 |
| Royalty Pharma PLCRPRX | 4.94% | $13.93M | 238,422 |
| Biogen Inc.BIIB | 4.79% | $13.50M | 66,507 |
| Gilead Sciences, Inc.GILD | 4.43% | $12.50M | 96,026 |
| United Therapeutics Corp.UTHR | 4.08% | $11.49M | 22,197 |
| Bio-Techne Corp.TECH | 3.73% | $10.53M | 146,019 |
| Illumina, Inc.ILMN | 3.51% | $9.89M | 48,231 |
| Protagonist Therapeutics, Inc.PTGX | 3.40% | $9.57M | 70,055 |
| Vericel Corp.VCEL | 3.27% | $9.21M | 200,298 |
| Alnylam Pharmaceuticals, Inc.ALNY | 3.17% | $8.93M | 43,457 |
| Incyte Corp.INCY | 3.06% | $8.62M | 72,136 |
| Repligen Corp.RGEN | 3.04% | $8.57M | 60,807 |
| Acadia Pharmaceuticals Inc.ACAD | 3.02% | $8.52M | 329,464 |
| Halozyme Therapeutics, Inc.HALO | 2.98% | $8.41M | 101,929 |
| Qiagen N.V. | 2.89% | $8.16M | 197,087 |
| BioMarin Pharmaceutical Inc.BMRN | 2.82% | $7.95M | 132,461 |
| Neurocrine Biosciences, Inc.NBIX | 2.66% | $7.50M | 44,979 |
| Exelixis, Inc.EXEL | 2.64% | $7.43M | 140,144 |
| BioCryst Pharmaceuticals, Inc.BCRX | 2.63% | $7.43M | 826,963 |
| Veracyte, Inc.VCYT | 2.60% | $7.34M | 158,435 |
| Collegium Pharmaceutical, Inc.COLL | 2.60% | $7.34M | 207,352 |
| Omeros Corp.OMER | 2.52% | $7.12M | 601,237 |
| PTC Therapeutics, Inc.PTCT | 2.50% | $7.04M | 103,541 |
| AnaptysBio, Inc.ANAB | 2.29% | $6.47M | 121,247 |
| Sarepta Therapeutics, Inc.SRPT | 2.21% | $6.24M | 420,180 |
| Ardelyx, Inc.ARDX | 1.97% | $5.55M | 1,120,704 |
| Legend Biotech Corp.LEGN | 1.56% | $4.40M | 237,196 |
| Invesco Government & Agency PortfolioCash or money market | 0.08% | $215.96K | 215,965 |
Holdings from the fund's latest Form N-PORT; expense ratio (net of fee waivers) from the risk/return summary of its prospectus; fund type from Form N-CEN. Prices are end-of-day closes adjusted for splits; total return also reinvests distributions.